{"id":648860,"date":"2017-04-13T03:58:48","date_gmt":"2017-04-13T03:58:48","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/"},"modified":"2017-04-13T03:58:48","modified_gmt":"2017-04-13T03:58:48","slug":"why-big-pharma-is-turning-to-biological-meds","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/","title":{"rendered":"Why big pharma is turning to biological meds"},"content":{"rendered":"

Why big pharma is turning to biological meds: <\/strong>Biological meds are increasingly being seen as more lucrative to pharma companies than the standard chemical kinds. While chemical drugs are based on small, stable molecules (and have been used since the industry emerged), their biological counterparts are based on much larger and more volatile proteins. Despite their lack of stability, biologics-based drugs have recently become more appealing to big pharma companies as they use our own DNA to cure us, making them more effective than chemical meds in treating genetic diseases such as diabetes and cancer, the Wall Street Journal\u2019s Preetika Rana explains<\/a> (runtime 2:53).<\/p>\n","protected":false},"excerpt":{"rendered":"

Why big pharma is turning to biological meds: Biological meds are increasingly being seen as more lucrative to pharma companies than the standard chemical kinds. While chemical drugs are based on small, stable molecules (and have been used since the industry emerged), their biological counterparts are based on much larger and more volatile proteins. Despite […]<\/p>\n","protected":false},"author":1,"featured_media":648861,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[9004],"tags":[72,2388],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-648860","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-worth-watching","tag-enterpriseam","tag-worth-watching","wpautop","entry"],"acf":{"mongo_id":"d9733d62-4ad1-4173-92b2-54c4b5a92aa8","order":"0","is_powered_by":true,"story_type":"1","photo_url":"https:\/\/ent.news\/2017\/4\/2285.jpg","photo_position":"above","related_issue":[648834],"teaser":"","voice_url":""},"yoast_head":"\nWhy big pharma is turning to biological meds - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why big pharma is turning to biological meds\" \/>\n<meta property=\"og:description\" content=\"Why big pharma is turning to biological meds: Biological meds are increasingly being seen as more lucrative to pharma companies than the standard chemical kinds. While chemical drugs are based on small, stable molecules (and have been used since the industry emerged), their biological counterparts are based on much larger and more volatile proteins. Despite […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2017-04-13T03:58:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Why big pharma is turning to biological meds\",\"datePublished\":\"2017-04-13T03:58:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/\"},\"wordCount\":112,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1\",\"keywords\":[\"EnterpriseAM\",\"worth watching\"],\"articleSection\":[\"Worth watching\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/\",\"name\":\"Why big pharma is turning to biological meds - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1\",\"datePublished\":\"2017-04-13T03:58:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why big pharma is turning to biological meds\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Why big pharma is turning to biological meds - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/","og_locale":"en_US","og_type":"article","og_title":"Why big pharma is turning to biological meds","og_description":"Why big pharma is turning to biological meds: Biological meds are increasingly being seen as more lucrative to pharma companies than the standard chemical kinds. While chemical drugs are based on small, stable molecules (and have been used since the industry emerged), their biological counterparts are based on much larger and more volatile proteins. Despite […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2017-04-13T03:58:48+00:00","og_image":[{"url":"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Why big pharma is turning to biological meds","datePublished":"2017-04-13T03:58:48+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/"},"wordCount":112,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1","keywords":["EnterpriseAM","worth watching"],"articleSection":["Worth watching"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/","url":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/","name":"Why big pharma is turning to biological meds - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1","datePublished":"2017-04-13T03:58:48+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#primaryimage","url":"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1","contentUrl":"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/13\/why-big-pharma-is-turning-to-biological-meds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Why big pharma is turning to biological meds"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?resize=600%2C400&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?resize=600%2C600&ssl=1","author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/ent.news\/2017\/4\/2285.jpg?fit=%2C&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":639664,"url":"https:\/\/enterpriseam.com\/egypt\/2024\/08\/13\/govt-to-end-meds-shortage-with-subsidized-loans-for-pharma-players\/","url_meta":{"origin":648860,"position":0},"title":"Gov\u2019t to end meds shortage with subsidized loans for pharma players","author":"enterpriseam admin","date":"13 August 2024","format":false,"excerpt":"Drug prices will soon see hikes ranging between 10-50%","rel":"","context":"In "PHARMA"","block_context":{"text":"PHARMA","link":"https:\/\/enterpriseam.com\/egypt\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2024\/8\/1023.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":614601,"url":"https:\/\/enterpriseam.com\/egypt\/2024\/02\/05\/pricier-meds-ahead\/","url_meta":{"origin":648860,"position":1},"title":"Pricier meds ahead?","author":"enterpriseam admin","date":"5 February 2024","format":false,"excerpt":"Some 1.5k drugs \u2014 9% of the total 17k sold in Egypt \u2014 have been hit by the shortage of raw materials","rel":"","context":"In "PHARMA"","block_context":{"text":"PHARMA","link":"https:\/\/enterpriseam.com\/egypt\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/241.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":636096,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/12\/20\/pharma-companies-health-ministry-negotiate-alternatives-to-med-price-increases\/","url_meta":{"origin":648860,"position":2},"title":"Pharma companies, Health Ministry negotiate alternatives to med price increases","author":"enterpriseam admin","date":"20 December 2017","format":false,"excerpt":"Pharma companies have begun proposing to the Health Ministry several alternatives to raising med prices that would help manufacturers reduce their losses, chairman of the Federation of Egyptian Industries\u2019 pharma division Ahmed El Ezaby tells Al Mal. The proposals include only raising prices on meds that were not affected by\u2026","rel":"","context":"In "Health + Education"","block_context":{"text":"Health + Education","link":"https:\/\/enterpriseam.com\/egypt\/category\/health-education\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":656349,"url":"https:\/\/enterpriseam.com\/egypt\/2024\/12\/03\/government-dues-owed-to-pharma-firms-hit-egp-50-bn\/","url_meta":{"origin":648860,"position":3},"title":"Government dues owed to pharma firms hit EGP 50 bn","author":"enterpriseam admin","date":"3 December 2024","format":false,"excerpt":"The pharma sector is set to implement phased price hikes affecting around 100 drugs per month","rel":"","context":"In "PHARMA"","block_context":{"text":"PHARMA","link":"https:\/\/enterpriseam.com\/egypt\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2024\/12\/101.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":651342,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/02\/09\/health-ministry-allows-pharma-companies-to-sell-old-meds-at-new-prices-for-6-weeks\/","url_meta":{"origin":648860,"position":4},"title":"Health Ministry allows pharma companies to sell old meds at new prices for 6 weeks","author":"enterpriseam admin","date":"9 February 2017","format":false,"excerpt":"The Health Ministry has decided to allow pharma companies to sell old meds at the new prices agreed upon last month for a six-week period to ensure medications in short supply remain available, ministry spokesman Khaled Megahed tells Al Shorouk. The decision to hike on medication prices, issued last month,\u2026","rel":"","context":"In "Health + Education"","block_context":{"text":"Health + Education","link":"https:\/\/enterpriseam.com\/egypt\/category\/health-education\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":560270,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/22\/ibnsina-to-distribute-bayer-meds-in-egypt-rameda-looks-to-invest\/","url_meta":{"origin":648860,"position":5},"title":"Ibnsina to distribute Bayer meds in Egypt, Rameda looks to invest","author":"enterpriseam admin","date":"22 February 2021","format":false,"excerpt":"Ibnsina Pharma has signed an agreement with Germany\u2019s Bayer to import and distribute products from its OTC and Rx-based portfolios, the companies said in a joint statement (pdf) today. Bayer wants to grow in Egypt: Bayer Consumer Health wants to increase sales by 30% in 2021 after recording sales of\u2026","rel":"","context":"In "PHARMA"","block_context":{"text":"PHARMA","link":"https:\/\/enterpriseam.com\/egypt\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/314.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/648860","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=648860"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/648860\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/648834"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media\/648861"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=648860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=648860"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=648860"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=648860"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=648860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}